MOLECULAR PATHOGENESIS OF MICROCARCINOMA OF THE THYROID

• 1. 一种区分甲状腺乳头状癌及甲状腺良性结节的分子标记物 [P] . 中国专利： CN110964819A . 2020-04-07
• 2. 甲状腺乳头状癌远处转移分子突变预测模型、方法及系统 [P] . 中国专利： CN109979532B . 2020.10.16
• 3. Molecular pathogenesis of microcarcinoma of the thyroid [P] . US11162141B2 . 2021-11-02

  机译： 甲状腺微癌的分子发病机制

• 4. METHOD FOR DIAGNOSING THYROID MICROCARCINOMA [P] . UA65261U . 2011-11-25

  机译： 诊断甲状腺微癌的方法

• 5. LOW MOLECULAR WEIGHT THYROID STIMULATING HORMONE RECEPTOR (TSHR) AGONISTS [P] . AU2016204845B2 . 2017-04-06

  机译： 低分子甲状腺刺激激素受体（TSHR）激动剂

• 1. Active surveillance as a management strategy for papillary thyroid microcarcinoma [J] . Huan Zhang, Xiangqian Zheng, Juntian Liu, 癌症生物学与医学（英文版 ） . 2020,第003期
• 2. Active surveillance as a management strategy for papillary thyroid microcarcinoma [J] . Huan Zhang, Xiangqian Zheng, Juntian Liu, 癌症生物学与医学：英文版 . 2020,第003期
• 3. Risk factors for cervical lymph node metastasis in papillary thyroid microcarcinoma: a study of 1,587 patients [J] . Xiangqian Zheng, Chen Peng, Ming Gao, 癌症生物学与医学：英文版 . 2019,第001期
• 4. Clinical significance of BRAFV^600E and TERT promoter mutation in papillary thyroid microcarcinoma [J] . Jincai Xue, Qinjiang Liu, Youxin Tian, 肿瘤学与转化医学（英文） . 2019,第002期
• 5. Molecular Aberrance in Papillary Thyroid Microcarcinoma Bearing High Aggressiveness: Identifying a "Tibetan Mastiff Dog" From Puppies [J] . Li Dapeng, Gao Ming, Li Xiaolong, Journal of cellular biochemistry. . 2016,第7期
• 6. Papillary thyroid microcarcinoma with fatal outcome: Evidence of tumor progression in lymph node metastases: Report of 3 cases, with morphological and molecular analysis [J] . PianaS., RagazziM., TalliniG., Human Pathology . 2013,第4期
• 7. A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma [J] . NiemeierL.A., KuffnerAkatsuH., SongC., Cancer: A Journal of the American Cancer Society . 2012,第8期
• 8. Texture analysis and imbalanced data processing for papillary thyroid microcarcinoma detection [C] . Fengqin Wei, Jianrui Ding, Chunping Ning, International Conference on Biological Information and Biomedical Engineering . 2018
• 9. Analyzing the role of thyroidal CD40 expression in the pathogenesis of Graves' disease. [D] . Huber, Amanda Katherine. 2011
• 10. Clinical Outcome Role of BRAFV600E and Molecular Pathways in Papillary Thyroid Microcarcinoma: Is It an Indolent Cancer or an Early Stage of Papillary Thyroid Cancer? [O] . Carmelo Nucera, Alfredo Pontecorvi 2012
• 11. Clinical outcome, role of BRAF(V600E), and molecular pathways in papillary thyroid microcarcinoma: is it an indolent cancer or an early stage of papillary thyroid cancer? [O] . Nucera, Carmelo, Pontecorvi, Alfredo 2012

• 1. Predictive factors for central lymph node metastases in papillary thyroid microcarcinoma [J] . Xin Wu ,Bing-Lu Li ,Chao-Ji Zheng . 世界临床病例杂志 . 2020,第008期
• 2. 合并桥本甲状腺炎的甲状腺乳头状癌免疫微环境分析 [C] . 王义增 ,谷寅天 ,姜若愚 . 第十届中国医师协会外科医师年会 . 2017
• 3. 23年甲状腺恶性肿瘤发病情况的分析和甲状腺滤泡癌、乳头状癌中粘附分子、转移抑制基因表达的病理学研究 [A] . 刘岩 . 2001